2021-05-17T12:41:41-05:00 2020-12-31 341874260 CBIZ MHM LLC 700 WEST 47TH STREET SUITE 1100 KANSAS CITY MO 64112 990 2020-01-01 431889037 BIONEXUS KC BION 8167537700 30 W PERSHING ROAD NO 210 KANSAS CITY MO 64108 DENNIS RIDENOUR PRESIDENT & CEO 8167537700 2021-05-17 1 DENNIS RIDENOUR 999009999 LISA BURKE P00220718 8169455500 2021-05-17 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z DENNIS RIDENOUR 30 W PERSHING ROAD NO 210 KANSAS CITY MO 64108 2127763 0 X WWW.BIONEXUSKC.ORG X 2000 MO THE PURPOSE OF THIS ORGANIZATION IS TO PROMOTE AND FOSTER DEVELOPMENT OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA AND TO PROVIDE A PLATFORM FOR DEVELOPMENT AND COOPERATION IN THE AREA OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA. 12 11 7 42 0 0 1561392 1017110 56446 17545 35293 20008 32151 -17009 1685282 1037654 518754 436244 0 0 761684 758581 0 0 8311 570708 361630 1851146 1556455 -165864 -518801 1774951 1256150 0 0 1774951 1256150 X THE PURPOSE OF THIS ORGANIZATION IS TO PROMOTE AND FOSTER DEVELOPMENT OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA AND TO PROVIDE A PLATFORM FOR DEVELOPMENT AND COOPERATION IN THE AREA OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA. 0 0 1181527 436244 17645 SEE SCHEDULE O 1181527 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 0 7 1 1 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 X 12 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X X SHARON NEWMAN 8167537700 30 W PERSHING ROAD STE 210 KANSAS CITY MO 64108 DENNIS RIDENOUR PRESIDENT & CEO 40.00 X X 223594 0 28021 KEITH A GARY VICE PRESIDENT 40.00 X X 183213 0 34851 WILLIAM S BERKLEY DIRECTOR (CHAIR) 1.00 X X 0 0 0 JEFF HARGROVES DIRECTOR (TREASURER AND SECRETARY) 0.30 X X 0 0 0 DONALD CRAIG BRATER DIRECTOR 0.10 X 0 0 0 DAVID FRANTZE DIRECTOR 0.50 X 0 0 0 IRVINE O HOCKADAY JR DIRECTOR 0.30 X 0 0 0 THOMAS SACK PHD DIRECTOR 0.50 X 0 0 0 ANNE D ST PETER DIRECTOR 0.50 X 0 0 0 MADELEINE M MCDONOUGH DIRECTOR 0.50 X 0 0 0 DEBORAH WILKERSON DIRECTOR 0.30 X 0 0 0 MARIA STECKLEIN FLYNN DIRECTOR 0.20 X 0 0 0 406807 0 62872 2 0 1 0 AGTECH ADVISORS LLC ANTHONY A SIMPSON 5510 CHOUTEAU ST SHAWNEE KS 66226 CONSULTING ON EST OF KC NEXUS FUND 159159 1 58960 85100 873050 1017110 ONE HEALTH SYMPOSIUM 900099 11545 11545 BIOINFORMATICS CONFERENCE 900099 6000 6000 17545 20513 20513 1072495 1073000 -505 -505 -505 0 58960 17109 -17109 -17109 MISCELLANEOUS REVENUE 900099 100 100 100 1037654 17645 0 2899 436244 436244 469679 293613 170965 5101 214394 135449 77494 1451 36600 5469 30667 464 37908 15742 21750 416 6811 1657 5154 19620 4773 14847 18994 17870 1116 8 4527 2350 2118 59 21787 16191 5441 155 47393 29771 17174 448 4180 3361 819 8002 6402 1589 11 15263 12498 2701 64 CONSULTANTS 167795 167745 50 MEMBERSHIPS AND DUES 14356 13314 1007 35 COVID-19 PREPAREDNESS P 10725 10725 TELEPHONE 10075 6309 3667 99 12102 2044 10058 1556455 1181527 366617 8311 1745349 1232411 104396 86915 14511 17481 15091 6258 1774951 1256150 0 0 X 1071896 790992 703055 465158 1774951 1256150 1774951 1256150 -518801 0 X 0 1 X 1 0 X 1724324 1603349 1667012 1561392 992550 7548627 1724324 1603349 1667012 1561392 992550 7548627 3687110 3861517 900 9083 27434 28028 20513 85958 106 32151 100 32357 7666942 0.50370 0.48550 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1167 1167 1198636 1199803 194980 48745 0 0 218742 226634 213305 194980 853661 1280492 2211 1231 1414 1167 6023 54686 56659 53326 48745 213416 320124 54140 49545 4595 50256 37370 12886 17481 X 1054763 17109 17109 1037654 0 1037654 1573564 17109 17109 1556455 0 1556455 PART X, LINE 2: BIONEXUS KC HAS BEEN GRANTED AN EXEMPTION FROM INCOME TAXES BY THE INTERNAL REVENUE SERVICE UNDER THE PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THERE WAS NO UNRELATED BUSINESS INCOME DURING 2019. THERE WAS UNRELATED BUSINESS INCOME DURING 2018, RELATED TO PARKING. THE ORGANIZATION RECEIVED REIMBURSEMENT DURING 2019 FOR THE TAXES PAID DURING 2018 RELATED TO THE PARKING. THE ORGANIZATION HAS EVALUATED THE STANDARDS REQUIRING DISCLOSURE OF UNCERTAIN TAX POSITIONS UNDER FASB ASC 740, INCOME TAXES, AND DETERMINED THAT THERE ARE NO MATERIAL MATTERS WHICH REQUIRE DISCLOSURE. PART XI, LINE 2D - OTHER ADJUSTMENTS: EVENT EXPENSES 17,109. PART XII, LINE 2D - OTHER ADJUSTMENTS: EVENT EXPENSES 17,109. ANNUAL DINNER 58960 58960 17109 58960 58960 17109 17109 -17109 1 UNIVERSITY OF MISSOURI 115 BUSINESS LOOP 70W MIZZOU NH RM 501 COLUBMIA MO 65211 436003859 170(B)(1)(A)(II) 149976 BIONEXUS KC 20-1 PATTON TIMOTHY COX, PHD UMKC; BIONEXUS KC 20-4 NEXUS OF ANIMAL AND HUMAN HEALTH RESEARCH GRANT JOAN COATES; BIONEXUS KC 20-6 NEXUS OF ANIMAL AND HUMAN HEALTH RESEARCH GRANT EMMA GRANT UNIVERSITY OF KANSAS CENTER FOR RESEARCH 2385 IRVING HILL ROAD LAWRENCE KS 660457568 480680117 501(C)(3) 100000 BIONEXUS KC 20-3 PATTON JINGXIN WANG, PHD KU; BIONEXUS KC 20-2 PATTON TRUST RESEARCH GRANT, MIZUKI AZUMA, PHD KANSAS STATE UNIVERSITY (KSU) 105 ANDERSON HALL MANHATTAN KS 665060100 480771751 501(C)(3) 100000 BIONEXUS KC 20-5 NEXUS OF ANIMAL AND HUMAN HEALTH RESEARCH GRANT, SHIH-KANG FAN, PHD; BIONEXUS KC 20-7 NEXUS OF ANIMAL AND HUMAN HEALTH RESEARCH GRANT MAJID JABERI-DOURAKI, PHD SAINT LUKE'S HOSPITAL OF KANSAS CITY 4401 WORNALL RD KANSAS CITY MO 64111 440545297 501(C)(3) 79990 BIONEXUS KC 20-3 QVIC PILOT GRANT FOR KANSAS CITY QUALITY & VALUE INNOVATION CONSORTIUM 4 0 PART I, LINE 2: GRANTS ARE FOR A ONE YEAR DURATION. GRANT RECIPIENTS AGREE TO PROVIDE A PROGRESS REPORT AT SIX MONTHS AND A SUMMARY TECHNICAL PROGRESS REPORT WITHIN 30 DAYS OF THE END OF THE PERFORMANCE TO INCLUDE: 1. A BRIEF SUMMARY OF TECHNICAL PROGRESS RELATIVE TO THE GOALS AND OBJECTIVES PROPOSED IN THE PROPOSAL. 2. A BRIEF STATEMENT CONCERNING THE EFFECTIVENESS AND BENEFITS REALIZED FROM THE COLLABORATIONS INVOLVED. GRANT RECIPIENTS AGREE TO PROVIDE (UPON REQUEST) A COPY OF ALL PROPOSALS SUBMITTED TO EXTERNAL FUNDING AGENCIES AS A RESULT OF THE SUPPORT PROVIDED AND SUBSEQUENTLY NOTIFY BIONEXUS KC OF ACCEPTANCE OR REJECTION THEREOF. IF THE GRANT RECIPIENT RECEIVES ALTERNATIVE FUNDS FOR SUPPORT OF THIS SPECIFIC PROJECT, BIONEXUS KC REQUESTS THAT THE RECIPIENT RETURN ANY UNEXPENDED FUNDS TO THE INSTITUTE SO THAT THEY CAN BE USED TO SUPPORT OTHER INVESTIGATORS. X X X X X 0 0 0 0 0 0 0 0 0 DENNIS RIDENOUR PRESIDENT & CEO 223594 0 0 0 0 0 21505 0 6516 0 251615 0 0 0 KEITH A GARY VICE PRESIDENT 183213 0 0 0 0 0 19368 0 15483 0 218064 0 0 0 FORM 990, PART III, LINE 4A 2020 UPDATES: 1. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT "PATH TO 2025" 2. CONVENE KC AND COVID-19 3. COLLABORATE2CURE 4. KANSAS CITY QUALITY AND VALUE INNOVATION CONSORTIUM 5. WORKFORCE DEVELOPMENT 6. RESEARCH DEVELOPMENT GRANT PROGRAMS 7. ANNUAL DINNER AND "SCIENCE TO ART" AUCTION 8. ONE HEALTH RESEARCH SYMPOSIUM 9. ONE HEALTH DAY 10. KC NEXUS FUND 1. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT: "PATH TO 2025" DESPITE THE CHALLENGES SURROUNDING COVID-19, BIONEXUS KC CONTINUED TO FOCUS ON REGIONAL EFFORTS TO BE A GLOBAL LEADER AT THE NEXUS OF HUMAN AND ANIMAL HEALTH: UNITING LEADERS AND SCIENTISTS TO IDENTIFY OPPORTUNITIES, AND ADVANCE LIFE SCIENCES RESEARCH. BIONEXUS KC'S PROGRAMMING CONTINUED TO FOCUS ON INITIATIVES IDENTIFIED AS OPPORTUNITIES IN THE PATH TO 2025, THE 10-YEAR STRATEGIC ASSESSMENT THAT WAS COMMISSIONED IN 2015 IN PARTNERSHIP WITH DELOITTE. THESE ACTIVITIES ARE DETAILED BELOW. IN LATE 2020, BIONEXUS KC VIRTUALLY CONVENED ITS OWN EXECUTIVE LEADERSHIP TEAM AND ITS BOARD OF DIRECTORS FOR A TWO-DAY STRATEGIC RETREAT FOCUSED ON EVALUATING AND PRIORITIZING THE ORGANIZATION'S CURRENT EFFORTS AND ITS FUTURE OPPORTUNITIES. AS A RESULT OF THE RETREAT, BIONEXUS KC LEADERSHIP DEVELOPED A FRAMEWORK THAT WILL BE APPLIED TO CONFIRM THE VALUE OF CURRENT EFFORTS AND EVALUATE FUTURE OPPORTUNITIES. 2. CONVENE KC AND COVID-19 IN RESPONSE TO COVID-19, BIONEXUS KC CONVENED THE LIFE SCIENCES AND HEALTHCARE COMMUNITY VIRTUALLY TO DISCUSS CONDITIONS ON THE FRONT LINES OF CARE AND RESEARCH. THE SERIES FEATURED THOUGHT LEADERS AND EXPERTS WHO HIGHLIGHTED CUTTING-EDGE INITIATIVES IMPACTING THE REGIONAL PANDEMIC RESPONSE AND GENERATED DISCUSSION OF HOW THE COMMUNITY COULD BE BETTER IN THE FIGHT AGAINST CORONAVIRUS. THE FOCUS OF CONVENE KC WAS TO UNIFY AND PROVIDE EDUCATION TO THE REGION WITH DATA AND RESEARCH. CONVENE KC FEATURED A DIVERSE SPEAKER LINEUP FROM ACROSS THE REGION AND COVERED A WIDE RANGE OF TOPICS, INCLUDING: UNITING TO COMBAT COVID-19 REGIONAL COVID-19 INITIATIVES HEALTH INEQUITIES AND DISPARITIES HIGHLIGHTED BY COVID-19 COMMUNITY RESPONSE IMPORTANCE OF TESTING AND REGIONAL TESTING EFFORTS CONTACT TRACING TELEHEALTH TECHNOLOGIES AND REMOTE CARE COMEBACK KC REGIONAL STRATEGY REGIONAL INNOVATION AND THE IGNITEX COVID-19 RESPONSE ACCELERATOR BY FOSTERING COLLABORATION DURING THIS TIME OF CRISIS, BIONEXUS KC FACILITATED IN HELPING THE KC REGION EMBRACE INNOVATION AND DEVELOP A RESPONSE TO COVID-19 THAT WAS UNIQUE AND EFFECTIVE. SUBSEQUENTLY, BIONEXUS KC RECEIVED A $42,900.00 GRANT FROM HEALTH FORWARD FOUNDATION FOR A PROJECT ENTITLED "COVID-19 PREPAREDNESS IN PATIENTS WITH CHRONIC CONDITIONS IN SAFETY NET PROVIDER POPULATIONS." THE STATED OBJECTIVE OF THIS PROJECT IS TO PROVIDE SAMUEL U. RODGERS HEALTH CENTER WITH A POPULATION LEVEL CLINICAL DECISION SUPPORT TOOL TO ENHANCE COVID-19 PREPAREDNESS AND IMPROVE HEALTH OUTCOMES AMONG DIABETIC PATIENTS WHO POSSESS HIGH RISK OF ICU ADMISSIONS AND DEATH DUE TO COMORBIDITIES AND SOCIOECONOMIC HEALTH DISPARITIES WITH THE HELP FROM ABADA HEALTH (FORMERLY HELIX HEALTH) AND A MIDWEST HEALTH CONNECTION, A HEALTH INFORMATION EXCHANGE NETWORK. 3. COLLABORATE2CURE BIONEXUS KC CREATED THE COLLABORATE2CURE (C2C) PROGRAM IN 2016 WITH THE GOAL OF STIMULATING REGIONAL SCIENTIFIC COLLABORATION AND DEVELOPING INNOVATIVE WAYS TO SOLVE SCIENTIFIC CHALLENGES. THE PROGRAM PROVIDES A PLATFORM FOR COLLABORATION, ALLOWING SCIENTISTS IN THE KC REGION TO SHARE THEIR RESEARCH AND TO BETTER COMPETE FOR RESEARCH FUNDING. BIONEXUS KC IDENTIFIES A TOPIC WITH SIGNIFICANT INTEREST TO RESEARCHERS WHICH ALIGNS WELL WITH REGIONAL EXPERTISE, AND THEN COORDINATES A SERIES OF PRESENTATIONS FROM RESEARCHERS OVER THE COURSE OF SEVERAL MONTHS. IN MID-2020, BIONEXUS KC LAUNCHED ITS FOURTH COLLABORATE2CURE SERIES TO CONVENE AUTISM SPECTRUM DISORDER (ASD) RESEARCHERS, CLINICIANS, PATIENTS, AND ADVOCATES IN THE HOPES OF FOSTERING PRODUCTIVE COLLABORATIONS. THE PROGRAM WAS CHAIRED BY DR. ZOHREH TALEBIZADEH OF CHILDREN'S MERCY AND THE UNIVERSITY OF MISSOURI KANSAS CITY. THE COLLABORATE2CURE MONTHLY VIRTUAL PROGRAM PROVIDED A PLATFORM FOR PARTNERSHIP, CONVENING THE REGION'S ROBUST AUTISM NETWORK, COMPRISED OF BASIC RESEARCHERS, CLINICIANS, PATIENT ADVOCACY GROUPS, AND START-UP COMPANIES TO SHARE THEIR RESEARCH AND EXPERTISE. OVER THE FIRST SIX EVENTS IN THE SERIES, MORE THAN 415 ATTENDEES CAME TOGETHER TO DISCUSS TOPICS RANGING FROM PERSONALIZED INTERVENTIONS TO COMORBIDITIES AND SUBTYPES. THE GOAL OF THE 2020 ASD SERIES WAS TO BRING TOGETHER DISCIPLINES TO LEARN ABOUT A VARIETY OF RESEARCH AND CLINICAL ISSUES RELATED TO ASD, AND TO FORMALIZE A PATIENT-CENTERED MIDWEST AUTISM RESEARCH CONSORTIUM BASED HERE IN KANSAS CITY. THIS CONSORTIUM WILL MAKE THE REGION MORE COMPETITIVE FOR RESEARCH FUNDING, MORE TARGETED CLINICAL INTERVENTIONS, AND RAISE REGIONAL AWARENESS OF THE IMPACT OF ASD ON INDIVIDUALS AND THEIR FAMILIES. 4. KANSAS CITY QUALITY AND VALUE INNOVATION CONSORTIUM THE KANSAS CITY QUALITY AND VALUE INNOVATION CONSORTIUM (KC QVIC) IS A NOVEL COLLABORATION OF STAKEHOLDERS COMMITTED TO IMPROVING THE VALUE OF HEALTHCARE IN KANSAS CITY. THE LONGTERM MISSION IS TO ELEVATE THE REGION AND TO SERVE AS A VEHICLE FOR MORE RAPIDLY TESTING THE EFFECTIVENESS OF NEW INNOVATIONS IN HEALTHCARE DELIVERY. THE FOCUS OF THE KC QVIC IS ON THE NEEDS OF THE COMMUNITY AND THE STRATEGIC PRIORITIES OF REGIONAL HOSPITALS AND HEALTH SYSTEMS. THE KC QVIC HAS FORMULATED TWO PROJECTS TO ENGAGE MULTIPLE HEALTH SYSTEMS IN A VALUE IMPROVEMENT PROJECT, SUPPORTED BY THE RESEARCH COMMUNITY. BOTH PROJECTS AIM TO IMPROVE HEALTH OUTCOMES: 1. OPIOID MANAGEMENT 2. TRANSITIONS IN CARE FOR HEART FAILURE THROUGHOUT 2020, THE KC QVIC CONTINUED HOSTING A MONTHLY COMMUNITY FORUM TO DISCUSS PRIORITIES TO ENHANCE THE VALUE OF CARE IN KANSAS CITY. THE OBJECTIVE OF STRENGTHENING AND LIFTING THE QUALITY AND VALUE OF HEALTHCARE WILL REQUIRE SUPPORT FROM EVERYONE IN THE HEALTHCARE COMMUNITY. THIS BROAD, PATIENT-CENTERED, HOLISTIC APPROACH WILL LEVERAGE RESOURCES TO TURN THIS VISION INTO A REALITY. IN SEPTEMBER 2020, BIONEXUS KC AWARDED THE KC QVIC A $79,900 GRANT TO FACILITATE DATA ACQUISITION, AMPLIFY MESSAGING, AND SUSTAIN GROWTH FOR THEIR FIRST TWO PILOT PROJECTS. 5. WORKFORCE DEVELOPMENT WORKFORCE DEVELOPMENT WAS IDENTIFIED IN BIONEXUS KC'S PATH TO 2025 REPORT AS A SIGNIFICANT THREAT TO AND CRITICAL WEAKNESS IN THE REGIONAL LIFE SCIENCE CLUSTER. THE 2020 ACTIVITIES IN SUPPORT OF WORKFORCE DEVELOPMENT INCLUDED THE FOLLOWING: STEM LEARNING ECOSYSTEMS REGIONAL AND NATIONAL ACTIVITIES. STRONG STEM LEARNING ECOSYSTEMS FEATURE DYNAMIC COLLABORATIONS AMONG SCHOOLS, OUT-OF-SCHOOL PROGRAMS, STEM EXPERT INSTITUTIONS (SUCH AS MUSEUMS, SCIENCE CENTERS, INSTITUTIONS OF HIGHER EDUCATION AND STEM PROFESSIONAL ASSOCIATIONS), THE PRIVATE SECTOR, COMMUNITY-BASED ORGANIZATIONS, YOUTH AND FAMILIES. THE KC STEM ALLIANCE HAS PROVIDED THE INFRASTRUCTURE TO SUPPORT ORGANIZING STEM RESOURCES IN THE REGION WITH ASSISTANCE FROM SEVERAL COMMUNITY ORGANIZATIONS, INCLUDING BIONEXUS KC. THE LOCAL INITIATIVE HAS BEEN RENAMED STEM CONNECT-KC AND THE LEADERSHIP TEAM EXPANDED TO INCLUDE ADDITIONAL ORGANIZATIONS. DESPITE THE SIGNIFICANT IMPACT ON IN-PERSON EDUCATION DURING THE PANDEMIC, STEM CONNECT-KC SWIFTLY CONVERTED TO VIRTUAL FORMATS FOR IMPACTFUL PROGRAM DELIVERY. BIONEXUS KC CONTINUES TO CONTRIBUTE TO THE ORGANIZATION'S SUCCESS THROUGH PARTICIPATION ON THEIR LEADERSHIP TEAM. REAL WORLD LEARNING CHANGING THE CORE FOUNDATION OF HIGH SCHOOL EDUCATION WAS A KEY RECOMMENDATION THAT CAME FROM THE KC RISING EXPERIENTIAL LEARNING TASK FORCE IN 2017. CO-CHAIRED BY KEITH GARY FROM BIONEXUS KC, AND LEIGH ANNE TAYLOR-KNIGHT FROM THE DEBRUCE FOUNDATION, THE YEARLONG EFFORT ENGAGED EDUCATION, BUSINESS, AND CIVIC LEADERS TO ASSESS EXPERIENTIAL LEARNING OPPORTUNITIES. FORTUNATELY, WORK HAD ALREADY BEGUN AT THE KAUFFMAN FOUNDATION TO ENGAGE IN THIS IMPORTANT WORK. BIONEXUS KC HAS CONTINUED TO SUPPORT THE KAUFFMAN FOUNDATION AS THEY PARTNER WITH STAKEHOLDERS ACROSS THE KC REGION TO SUPPORT SYSTEMIC INTEGRATION OF MARKET VALUE ASSETS (MVAS; DUAL COLLEGE CREDITS, ENTREPRENEURIAL EXPERIENCES, INDUSTRY RECOGNIZED CREDENTIALS, WORK EXPERIENCES) INTO SCHOOLS. THE FOUNDATION'S EARLY RESEARCH CONVERGED WITH OBSERVATIONS OF LOCAL EMPLOYERS AND WORKFORCE GROUPS THAT RWL MUST BECOME AN INTEGRAL PART OF THE EDUCATION SYSTEM FOR STUDENTS TO LEAVE FUTURE READY. CURRENTLY, THE INITIATIVE FUNDS OVER 30 SCHOOL DISTRICTS IN THE KC REGION BENEFITTING APPROXIMATELY 100,000 STUDENTS. BIOTECHNICIAN ASSISTANT CREDENTIALING EXAM (BACE) BIONEXUS KC BEGAN ENGAGING INDUSTRY PARTNERS TO SHARE SPECIFIC DETAILS OF THE BACE CREDENTIAL AND ENGAGE IN DISCUSSIONS OF ITS RELEVANCE TO COMPANIES AND THE POTENTIAL SIGNIFICANCE FOR ASSESSING CANDIDATES FOR EMPLOYMENT. DEVELOPED JOINTLY BY THE UNIVERSITY OF FLORIDA AND BIOFLORIDA (REPRESENTING 3 FORM 990, PART III, LINE 4A 6. BIONEXUS KC'S RESEARCH DEVELOPMENT GRANT PROGRAMS BIONEXUS KC'S RESEARCH DEVELOPMENT GRANTS PROGRAM IS DESIGNED TO GENERATE PRELIMINARY DATA THAT SUPPORT SUBMISSION OF MAJOR MULTIDISCIPLINARY RESEARCH PROPOSALS TO GOVERNMENT OR PRIVATE FUNDING AGENCIES. APPLICANTS RECEIVE WRITTEN PEER REVIEWS, REGARDLESS OF WHETHER THEIR PROJECT RECEIVED FUNDING, TO HELP THEM IMPROVE FUTURE GRANT APPLICATIONS. THIS IS A VALUED SERVICE APPRECIATED BY ALL TEN STAKEHOLDERS. THE COVID-19 PANDEMIC PRESENTED UNIQUE CHALLENGES TO BIONEXUS KC'S RESEARCH DEVELOPMENT GRANT PROGRAM, ONE OF ITS OLDEST AND MOST POPULAR PROGRAMS. WITH RESEARCHERS LOCKED DOWN AND SHUT OUT OF THEIR LABORATORIES, GRANT PROJECTS CAME TO AN ABRUPT HALT. ONCE THE LOCKDOWN WAS LIFTED, GRANTEES RETURNED TO GENERATING PRELIMINARY DATA SUPPORTING SUBMISSION OF MAJOR MULTIDISCIPLINARY RESEARCH PROPOSALS TO GOVERNMENT OR PRIVATE FUNDING AGENCIES. SINCE 2003, BIONEXUS KC HAS AWARDED $5,666,183 IN GRANTS. FROM THE PERIOD OF 2009-2019, THE RETURN ON INVESTMENT HAS BEEN 11:1 (FOR EVERY $1 INVESTED, $11.10 RETURNED FROM EXTERNAL FUNDING). TOTAL FOLLOW-ON FUNDING SINCE 2003 IS $62,894,631 FROM FEDERAL SOURCES AND FOUNDATIONS. THE 2020 BIONEXUS KC RESEARCH DEVELOPMENT GRANT PORTFOLIO INCLUDES: THE BLUE KC "TRANSFORMING KC HEALTH RESEARCH GRANT" (FORMERLY OUTCOMES RESEARCH) PROGRAM: FOCUS ON PARTNERSHIPS AIMING TO ADDRESS SOCIOECONOMIC AND ENVIRONMENTAL BARRIERS TO HEALTH THROUGH RESEARCH ON IMPROVING ACCESS TO NUTRITIOUS FOODS IN NUTRITIONALLY INSECURE COMMUNITIES. PARTNERING WITH BLUE CROSS AND BLUE SHIELD OF KANSAS CITY TO MANAGE THIS GRANT, BIONEXUS KC IS ADMINISTERING YEAR TWO OF THIS $400,000 GRANT WAS AWARDED TO THE PARTNERSHIP BETWEEN THE COMMUNITY HEALTH COUNCIL OF WYANDOTTE COUNTY (CHC), THE UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE (KUMC) AND VIBRANT HEALTH. THE RESEARCH WILL NOT ONLY IDENTIFY SUCCESSFUL STRATEGIES TO ENSURE MEMBERS HAVE SUSTAINABLE ACCESS TO HEALTHY FOOD AND THE CAPACITY FOR HEALTH FOOD PREPARATION, BUT ALSO DEMONSTRATE ASSOCIATED IMPROVEMENTS IN HEALTH OUTCOMES. PAUL PATTON CHARITABLE TRUST GRANTS: THIS GRANT PROGRAM FOCUSES ON GENETIC DISEASES MAINLY AFFECTING CHILDREN. THE FUNDS FOR THIS PROGRAM ARE PROVIDED BY THE PAUL PATTON TRUST, TED C. MCCARTER, WILLIAM EVANS JR. AND BANK OF AMERICA, N.A., TRUSTEE. BIONEXUS KC AWARDED GRANTS OF UP TO $50,000 TO THREE RESEARCHERS, TWO AT THE UNIVERSITY OF KANSAS AND ONE AT THE UNIVERSITY OF MISSOURI-KANSAS CITY. NEXUS OF HUMAN AND ANIMAL HEALTH GRANTS: THIS GRANT PROGRAM FOCUSES ON BIOMEDICAL RESEARCH PROJECTS, RANGING FROM USING NATURALLY OCCURRING DISEASES IN ANIMALS AS A MODEL FOR ASSESSING HUMAN DRUG EFFICACY TO REPURPOSING HUMAN DRUGS FOR USE IN ANIMAL DISEASES. IN 2019, FUNDED BY THE HALL FAMILY FOUNDATION, BIONEXUS KC AWARDED $50,000 GRANTS TO FOUR RESEARCHERS, TWO AT KANSAS STATE UNIVERSITY, ONE AT THE UNIVERSITY OF MISSOURI, AND ONE AT THE UNIVERSITY OF MISSOURI-KANSAS CITY. 7. 2020 ANNUAL EVENT AND "SCIENCE TO ART" AUCTION BIONEXUS KC'S OCTOBER 22, 2020 VIRTUAL ANNUAL EVENT BROUGHT TOGETHER 210 UNIQUE ATTENDEES INCLUDING REGIONAL LIFE SCIENCES LEADERS AND STUDENTS, TO HIGHLIGHT COLLABORATION AND OPPORTUNITIES THAT LIE AHEAD. THE KC REGION HAS SOME OF THE BEST RESEARCHERS AND CLINICIANS WORKING IN SOME OF THE MOST INNOVATIVE HEALTHCARE SYSTEMS. THE THEME FOR THIS YEAR'S ANNUAL EVENT WAS, "LEARN. ADAPT. THRIVE" WITH THE MESSAGE THAT "KANSAS CITY WILL BE AT THE FOREFRONT AS WE LEARN NOVEL WAYS TO COLLABORATE, ADAPT OUR METHODS TO FIT OUR NEW NORMAL AND WORK TOGETHER TO BUILD A FUTURE IN WHICH WE ALL THRIVE." THE EVENT FEATURED CALANEET BALAS, PRESIDENT & CEO OF THE ALS ASSOCIATION, AN ORGANIZATION WITH EXPERIENCE IN BUILDING A ROBUST AND REACTIVE ECOSYSTEM OF COLLABORATION AND INNOVATION. BALAS'S COMMENTS WERE HEAVILY TIED TO THE PANDEMIC, AS THE ALS ASSOCIATION QUICKLY ADAPTED BY PROVIDING REMOTE SUPPORT AND UTILIZING TECHNOLOGY FOR MEANINGFUL CARE SERVICE INTERVENTIONS. IN 2014, THE ICE BUCKET CHALLENGE CREATED AN UNPRECEDENTED OPPORTUNITY TO EXPAND AMYOTROPHIC LATERAL SCLEROSIS (ALS) RESEARCH AND CARE. THROUGHOUT 2020, BIONEXUS KC ENGAGED WITH POWERFUL ORGANIZATIONS EMBEDDED WITHIN KC'S LIFE SCIENCES AND HEALTHCARE COMMUNITY. WITH AN EFFECTIVE AND RESPONSIVE ECOSYSTEM, THE REGION LEVERAGED ITS EXPERTISE, ASSETS AND DETERMINATION IN FIELDS SUCH AS RARE DISEASE, INFORMATICS AND HEALTH EQUITY. THE REGION CAME TOGETHER TO LEARN, ADAPT, AND THRIVE BY IDENTIFYING AND IMPLEMENTING MEANINGFUL CHANGE AS THE REGION SHIFTS INTO ITS NEXT PHASE. OUR ANNUAL EVENT FEATURED CALANEET BALAS, PRESIDENT & CEO OF THE ALS ASSOCIATION, AND FOCUSED ON BUILDING A RESILIENT AND RESPONSIVE ECOSYSTEM THAT COULD RAPIDLY RESPOND TO SUPPORT INNOVATION AND THE DEVELOPMENT OF NEW TREATMENTS, EVEN IN TIMES OF CRISIS. OUR ONE HEALTH RESEARCH SYMPOSIUM FOCUSED ON BIOSENSORS AND SHOWCASED HOW OUR REGION IS USING THE CONSTANT STREAMS OF DATA PRODUCED TO DRAMATICALLY IMPROVE THE CARE AND TREATMENT OF HUMANS, ANIMALS, AND THE ENVIRONMENT. THE EVENT ENDED WITH FIVE TAKEAWAYS FROM DENNIS RIDENOUR, PRESIDENT AND CEO. LOOK AT EVERYTHING THROUGH A LENS OF DIVERSITY TO SEE HOW THE SYSTEMS BUILT HAVE DISADVANTAGED PEOPLE OF COLOR AND FIND WAYS TO CHANGE IT. EMPOWER RESEARCHERS TO EXPLORE NEW FIELDS AND TURN THAT RESEARCH INTO PRODUCTS OR SERVICES THAT IMPROVE LIVES. CONNECT WITH BIONEXUS KC, INFORM ORGANIZATIONS ABOUT AREAS OF INTEREST. HELP IDENTIFY NEW AND EXCITING AREAS OF OPPORTUNITY FOR THE REGION. PROMOTE COLLABORATION. THE SCIENCE TO ART SILENT AUCTION RAISED OVER $5,000 WHICH WAS MATCHED BY BIONEXUS KC TO SUPPORT STEAM EDUCATION, SPECIFICALLY BIOGENEIUS, PREP-KC, SCIENCE CITY AND THE GREATER KANSAS CITY SCIENCE & ENGINEERING FAIR, AND FREE EDUCATIONAL PROGRAMS AT THE KEMPER MUSEUM. 8. ONE HEALTH RESEARCH SYMPOSIUM BIONEXUS KC HOSTED THE ANNUAL ONE HEALTH RESEARCH SYMPOSIUM AS A VIRTUAL MEETING ON NOVEMBER 16 NOVEMBER 18 FROM 11:30 AM 1:00 PM. THIS YEAR'S ONE HEALTH RESEARCH SYMPOSIUM WAS FOCUSED ON BIOSENSORS, DEVICES AND TECHNOLOGY USED TO MONITOR THE HEALTH OR STATUS OF HUMANS, ANIMALS, OR THE ENVIRONMENT. BIOSENSORS AND WEARABLE SENSORS HAVE RECENTLY BEEN GARNERING MORE ATTENTION AS THEY OFFER OPPORTUNITIES TO ACCESS CONTINUOUS, REAL-TIME DATA MONITORING. FOR HEALTH APPLICATIONS, THE DATA IS OFTEN ACQUIRED USING NON-INVASIVE MEANS, WHICH HAS BEEN SHOWN TO ENHANCE AND INCREASE PATIENT ENGAGEMENT AND CAN PROVIDE EARLY DETECTION OF ABNORMAL CONDITIONS. THE VIRTUAL, 3-DAY EVENT WAS CO-CHAIRED BY DR. SUSAN WERNIMONT FROM HILL'S PET NUTRITION, INC. BELOW ARE HIGHLIGHTS FROM THIS YEAR'S EVENT: A TOTAL OF 366 PEOPLE IN ACADEMIA AND INDUSTRY ATTENDED THE THREE-DAY, SYMPOSIUM, OF WHICH 209 WERE UNIQUE ATTENDEES. NOVEMBER 16: THE TOPIC FOR NOVEMBER 16 WAS "WEARABLE/IMPLANTABLE SENSORS." THE EVENT WAS KICKED OFF BY KEYNOTE SPEAKER DR. B. DUNCAN LASCELLES, PROFESSOR OF TRANSLATIONAL PAIN RESEARCH AND MANAGEMENT FROM NORTH CAROLINA STATE UNIVERSITY, COLLEGE OF VETERINARY MEDICINE. HIS TALK WAS ABOUT "THE FUTURE OF IMPROVED DIAGNOSIS AND MONITORING." HIS RESEARCH AND PRESENTATION FOCUSED ON IMPROVEMENT OF PAIN CONTROL IN COMPANION ANIMALS USING HIGH-TECH SENSORS WHICH COULD PLAY A ROLE IN ENHANCING OUTCOMES FOR HUMANS. NOVEMBER 17: THE TOPIC WAS "BIOCHEMICAL SENSORS/ CAREER PANEL DISCUSSION." NOVEMBER 18: THE TOPIC WAS "ENVIRONMENTAL SENSORS." 9. ONE HEALTH DAY BIONEXUS KC PARTNERED WITH KANSAS STATE UNIVERSITY OLATHE, BIOKANSAS, KU EDWARDS CAMPUS AND FRONTIERS: UNIVERSITY OF KANSAS CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE FOR THE NOVEMBER 19, 2021 "KANSAS CITY ONE HEALTH DAY." THIS EVENT IS PART OF AN ANNUAL, INTERNATIONAL EVENT FOCUSED ON COMPLEX COLLABORATIONS ACROSS MULTIPLE DISCIPLINES TO ACHIEVE OPTIMAL HEALTH FOR PEOPLE, ANIMALS, AND THE ENVIRONMENT REFERRED TO AS ONE HEALTH. THE EVENT FEATURED SEVERAL PROMINENT RESEARCHERS IN THE BI-STATE REGION WHO EXPLORED VARIOUS ASPECTS OF "BIOSENSORS AND THE FUTURE IMPACT." THE EVENT INCLUDED A VIRTUAL STUDENT POSTER COMPETITION. BIONEXUS KC AWARDED SCHOLARSHIPS TO THREE STUDENT WINNERS, ONE EACH FROM THE GRADUATE, HIGH SCHOOL AND UNDERGRADUATE DIVISIONS. 10. KC NEXUS FUND IN THE FACE OF THE SEVERE ECONOMIC IMPACTS CAUSED BY THE ONSET OF COVID-19, DEVELOPMENT OF THE KC NEXUS FUND CONTINUED TO MAKE SIGNIFICANT STRIDES, MARCHING THE REGION ONE STEP CLOSER TO HAVING A PROOF-OF-CONCEPT FUND FOCUSED SOLELY ON ADVANCING LIFE SCIENCES AND HEALTHCARE TECHNOLOGIES. IN 2020, BIONEXUS KC CONTINUED TO MAKE TREMENDOUS PROGRESS ON ESTABLISHING THE KC NEXUS FUND. KEY ACCOMPLISHMENTS INCLUDE: RECEIVING A $300,000 EDA BUILD TO SCALE GRANT TO SUPPORT FUND ESTABLISHMENT. SECURING COMMITMENTS FROM AREA LIFE SCIENCE LEADERS TO SERVE ON FUND INDUSTRY ADVISORY COMMITTEES VALIDATING THE KC NEXUS FUND APPROACH AND MODEL WITH BIONEXUS KC STAKEHOLDERS AND REGIONAL LEADERS FORM 990, PART III, LINE 4A DEVELOPING AN EVER-GROWING PIPELINE OF PROJECTS THAT FIT THE FUND'S THESIS WHILE THE REGION HAS IMPROVED ACCESS TO CAPITAL FOR ALL ENTREPRENEURS, THERE IS STILL A LACK OF UNDERSTANDING AND SUPPORT FOR LIFE SCIENCE ENTREPRENEURS, SPECIFICALLY. WITH THE INFRASTRUCTURE FOR THE KC NEXUS FUND NEARLY COMPLETE, BIONEXUS KC IS SET TO OFFICIALLY LAUNCH THE FUND IN 2021 AND WILL BEGIN MAKING INVESTMENTS THAT WILL IMPACT THE REGION ALMOST IMMEDIATELY. FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION HAS A POLICY FOR THE ORGANIZATION'S AUDIT COMMITTEE TO REVIEW THE 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION OF THE ORGANIZATION'S PRESIDENT IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. IN 2013 THE ORGANIZATION CREATED A COMPENSATION COMMITTEE AND CONDUCTED A COMPENSATION STUDY TO FURTHER REFINE THE COMPENSATION PROCESS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST.